Immunogenicity of COVID-19 Vaccine Co-administration with Influenza Vaccine in Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions

Immune Response to SARS-CoV-2

Interventions

BIOLOGICAL

Bivalent mRNA SARS-CoV-2 vaccine

Administering a booster dose of the bivalent mRNA vaccine BNT162b2

BIOLOGICAL

Quardrivalent influenza vaccine

Administering a VaxigripTetra™

Trial Locations (1)

Faculty of Medicine, Prince of Songkla University, Songkhla

All Listed Sponsors

lead

Prince of Songkla University

OTHER

NCT06831786 - Immunogenicity of COVID-19 Vaccine Co-administration with Influenza Vaccine in Healthy Volunteers | Biotech Hunter | Biotech Hunter